Everolimus-associated Acute Kidney Injury in Patients with Metastatic Breast Cancer

Recently, everolimus (Evl) has been introduced in the management of hormone receptor-positive metastatic breast cancer, in combination with aromatase inhibitors. Evl-induced acute kidney injury has hitherto been described in other malignancies, especially renal cell cancer, but only once before in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, A., Rao, N. S., Malhotra, K. P., Rastogi, M., Khurana, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590422/
https://www.ncbi.nlm.nih.gov/pubmed/28904441
http://dx.doi.org/10.4103/ijn.IJN_304_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590422/
https://www.ncbi.nlm.nih.gov/pubmed/28904441
http://dx.doi.org/10.4103/ijn.IJN_304_16

Ejemplares similares